Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Big pharma’s key third-quarter data
EP Vantage
Tue, 06/28/22 - 10:37 am
GSK
Roche
Pfizer
JNJ
AstraZeneca
Novo Nordisk vaccines
clinical trials
pneumococcal disease
crovalimab
rheumatoid arthritis
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
Fri, 06/24/22 - 10:26 am
AstraZeneca
Wilson disease
Alexion
ALXN1840
PhaseBio’s Reversal Agent for Astra’s Brilinta could Spell Success for Both
BioSpace
Thu, 06/23/22 - 10:32 am
PhaseBio
AstraZeneca
Brilinta
antiplatelet therapy
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
Endpoints
Wed, 06/22/22 - 06:55 pm
AstraZeneca
China
COPD
drug manufacturing
AZ preps FDA filing for $3.6bn amyloidosis drug eplontersen
Pharmaforum
Tue, 06/21/22 - 10:57 am
AstraZeneca
eplontersen
Ionis
ATTR
Rumor mill says AstraZeneca may be eyeing a takeover of Mereo
Pharmaforum
Fri, 06/17/22 - 10:41 am
AstraZeneca
Mereo BioPharma
M&A
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
Motley Fool
Tue, 06/14/22 - 11:42 am
AstraZeneca
breast cancer
Enhertu
AstraZeneca trots out Evusheld data to expand the COVID preventive drug into the treatment arena
Fierce Pharma
Wed, 06/8/22 - 11:09 pm
AstraZeneca
Evusheld
COVID-19
Pascal Soriot wouldn't 'do anything differently' in Covid-19 vaccine development — report
Endpoints
Tue, 06/7/22 - 10:09 am
AstraZeneca
Pharma CEOs
Pascal Soriot
vaccines
COVID-19
ASCO22: Enhertu aces key HER2-low test in breast cancer
Pharmaforum
Mon, 06/6/22 - 09:43 am
ASCO 2022
AstraZeneca
Daiichi Sankyo
Enhertu
HER2-low breast cancer
breast cancer
Knighthood for AstraZeneca's Pascal Soriot
Spectator Australia
Thu, 06/2/22 - 10:18 am
AstraZeneca
Pascal Soriot
Pharma CEOs
Former AstraZeneca exec committed insider trading on landmark 2019 Enhertu deal, SEC alleges
Endpoints
Tue, 05/31/22 - 10:39 am
AstraZeneca
insider trading
SEC
Enhertu
Daiichi Sankyo
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
Pharmaforum
Mon, 05/30/22 - 10:23 am
ESMO
breast cancer
antibody-drug conjugate
AstraZeneca
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool
Mon, 05/30/22 - 10:15 am
AstraZeneca
FDA
Imfinzi
tremelimumab
liver cancer
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
Endpoints
Wed, 05/25/22 - 11:47 pm
Pfizer
HHS
Paxlovid
Merck
molnupiravir
AstraZeneca
Evusheld
COVID-19
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
Yahoo/Zacks.com
Wed, 05/25/22 - 10:36 am
AstraZeneca
Europe
EMA
vaccines
COVID-19
boosters
Vaxzevria
At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
Endpoints
Mon, 05/23/22 - 06:45 pm
AstraZeneca
IPOs
Enstasis
antibiotics
Pfizer, Merck, AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Fierce Pharma
Tue, 05/17/22 - 10:43 am
Big Pharma
earnings
Pfizer
Merck
AstraZeneca
COVID-19
Moderna Therapeutics
BioNTech
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
Endpoints
Tue, 05/17/22 - 10:36 am
AstraZeneca
COVID-19
antibodies
RQ Biotechnology
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »